The artificial urinary sphincter (AUS) is an externally controlled urethral occlusion device used to treat urinary incontinence due to reduced outlet resistance following prostate surgery.

Urethral drug-coated balloons (e.g., Optilume®) are devices that use balloon catheters to open the urethra or prostate and transfer paclitaxel from the balloon to help with obstructive urinary …

The purpose of insertion of an absorbable nasal valve implant in individuals who have symptomatic nasal valve obstruction due to nasal valve collapse (NVC) is to provide a …

The prostatic urethral lift (PUL) procedure involves the insertion of one or more permanent implants into the prostate, which retracts prostatic tissue and maintains an expanded urethral …

For individuals who utilize an anal insert for the treatment of fecal incontinence (FI) the evidence includes systematic and observational reviews. Relevant outcomes are symptoms, change in …

Interspinous and interlaminar implants (spacers) stabilize or distract the adjacent lamina and/or spinous processes and restrict extension to reduce pain in individuals with lumbar spinal …

Minimally invasive treatments are options to relieve symptoms of benign prostatic hyperplasia (BPH) while minimizing hospitalizations and complications of other treatments.

In 2022, the National Institute for Health and Care Excellence (NICE) issued an interventional procedures guidance on prostatic urethral temporary implant insertion for lower urinary tract …

Implantable peripheral nerve stimulation (PNS) is a percutaneous system consisting of leads, electrodes, and pulse transmitter that delivers electrical impulses to peripheral nerves. Leads …

Access Wellmark's InterQual® criteria and SmartSheets™ for streamlined medical policy reviews and authorization requests. Simplify your workflow with these trusted tools.